WallStreetZen

NASDAQ: LMAT
Lemaitre Vascular Inc Earnings & Revenue

LMAT past earnings growth

How has LMAT's earnings growth performed historically?
Company
71.95%
Industry
98.7%
Market
104.01%
LMAT's earnings have grown faster (22.08% per year) than the US Medical Instruments & Supplies industry average (16.05%)
Performance
LMAT's earnings have grown slower (22.08% per year) than the US market average (30.53%)
Performance
LMAT's earnings growth is accelerating - its growth over the last year (71.95%) is above its 5-year compound annual rate (22.08%)
Performance

LMAT past revenue growth

How has LMAT's revenue growth performed historically?
Company
31.26%
Industry
19.14%
Market
41.43%
LMAT's revenue has grown faster (12.87% per year) than the US Medical Instruments & Supplies industry average (12.26%)
Performance
LMAT's revenue has grown slower (12.87% per year) than the US market average (19.54%)
Performance
LMAT's revenue growth is accelerating - its growth over the last year (31.26%) is above its 5-year compound annual rate (12.87%)
Performance

LMAT earnings and revenue history

Current Revenue
$150.5M
Current Earnings
$28.8M
Current Profit Margin
19.1%
LMAT's has demonstrated consistent long-term earnings growth over the past 10 years (464%)
Performance

LMAT Return on equity

Current Company
16.5%
Current Industry
14.1%
Current Market
23.1%
LMAT's Return on Equity (16.5%) shows a company that is not efficient at transforming shareholder equity into returns
Performance

LMAT Return on assets

Current Company
11.4%
Current Industry
9%
LMAT is generating higher Return on Assets (11.4%) than the US Medical Instruments & Supplies industry average (9.08%)
Performance

LMAT Return on capital employed

Current Company
17.14%
Current Industry
11%
LMAT's ability to generate Return on Capital (17.14%) has decreased compared to 3 years ago (22.49%)
Performance

LMAT earnings dates

Next earnings date
Oct 28, 2021

Lemaitre Vascular Earnings & Revenue FAQ

What were LMAT's earnings last quarter?

On Invalid Date, Lemaitre Vascular (NASDAQ: LMAT) reported Q2 2021 earnings per share (EPS) of $0.40, up 135.29% year over year. Total Lemaitre Vascular earnings for the quarter were $8.30 million. In the same quarter last year, Lemaitre Vascular's earnings per share (EPS) was $0.17.

What was LMAT's earnings growth in the past year?

As of Q4 2021, Lemaitre Vascular's earnings has grown 71.95% year over year. This is 26.75 percentage points lower than the US Medical Instruments & Supplies industry earnings growth rate of 98.7%. Lemaitre Vascular's earnings in the past year totalled $28.77 million.

What is LMAT's earnings date?

Lemaitre Vascular's earnings date is Invalid Date. Add LMAT to your watchlist to be reminded of LMAT's next earnings announcement.

What was LMAT's revenue last quarter?

On Invalid Date, Lemaitre Vascular (NASDAQ: LMAT) reported Q2 2021 revenue of $40.67 million up 63.66% year over year. In the same quarter last year, Lemaitre Vascular's revenue was $24.85 million.

What was LMAT's revenue growth in the past year?

As of Q4 2021, Lemaitre Vascular's revenue has grown 31.26% year over year. This is 12.12 percentage points higher than the US Medical Instruments & Supplies industry revenue growth rate of 19.14%. Lemaitre Vascular's revenue in the past year totalled $150.52 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.